 Brain Neoplasms
"Brain Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain.
| Descriptor ID |
D001932
|
| MeSH Number(s) |
C04.588.614.250.195 C10.228.140.211 C10.551.240.250
|
| Concept/Terms |
Brain Neoplasms- Brain Neoplasms
- Neoplasms, Brain
- Brain Neoplasm
- Neoplasm, Brain
- Brain Tumors
- Brain Tumor
- Tumor, Brain
- Tumors, Brain
Brain Cancer- Brain Cancer
- Brain Cancers
- Cancer, Brain
- Cancers, Brain
- Malignant Neoplasms, Brain
- Brain Malignant Neoplasm
- Brain Malignant Neoplasms
- Malignant Neoplasm, Brain
- Cancer of Brain
- Cancer of the Brain
- Neoplasms, Brain, Malignant
- Brain Neoplasms, Malignant
- Brain Neoplasm, Malignant
- Malignant Brain Neoplasm
- Malignant Brain Neoplasms
Brain Tumor, Recurrent- Brain Tumor, Recurrent
- Brain Tumors, Recurrent
- Recurrent Brain Tumor
- Recurrent Brain Tumors
Malignant Primary Brain Tumors- Malignant Primary Brain Tumors
- Primary Malignant Brain Tumors
- Malignant Primary Brain Neoplasms
- Primary Malignant Brain Neoplasms
- Brain Neoplasms, Malignant, Primary
- Brain Neoplasms, Primary Malignant
Benign Neoplasms, Brain- Benign Neoplasms, Brain
- Benign Neoplasm, Brain
- Brain Benign Neoplasm
- Brain Benign Neoplasms
- Neoplasms, Brain, Benign
- Brain Neoplasms, Benign
- Benign Brain Neoplasm
- Benign Brain Neoplasms
- Brain Neoplasm, Benign
Brain Tumor, Primary- Brain Tumor, Primary
- Brain Tumors, Primary
- Primary Brain Tumor
- Primary Brain Tumors
- Neoplasms, Brain, Primary
- Brain Neoplasm, Primary
- Brain Neoplasms, Primary
- Primary Brain Neoplasm
- Primary Brain Neoplasms
|
Below are MeSH descriptors whose meaning is more general than "Brain Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Brain Neoplasms".
This graph shows the total number of publications written about "Brain Neoplasms" by people in this website by year, and whether "Brain Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 7 | 1 | 8 | | 1997 | 10 | 0 | 10 | | 1998 | 7 | 1 | 8 | | 1999 | 8 | 3 | 11 | | 2000 | 9 | 1 | 10 | | 2001 | 4 | 2 | 6 | | 2002 | 6 | 1 | 7 | | 2003 | 15 | 2 | 17 | | 2004 | 9 | 2 | 11 | | 2005 | 5 | 1 | 6 | | 2006 | 15 | 1 | 16 | | 2007 | 11 | 1 | 12 | | 2008 | 12 | 0 | 12 | | 2009 | 22 | 1 | 23 | | 2010 | 25 | 0 | 25 | | 2011 | 8 | 0 | 8 | | 2012 | 23 | 4 | 27 | | 2013 | 22 | 3 | 25 | | 2014 | 32 | 1 | 33 | | 2015 | 48 | 3 | 51 | | 2016 | 35 | 7 | 42 | | 2017 | 43 | 5 | 48 | | 2018 | 38 | 4 | 42 | | 2019 | 48 | 5 | 53 | | 2020 | 48 | 4 | 52 | | 2021 | 49 | 7 | 56 | | 2022 | 45 | 1 | 46 | | 2023 | 43 | 1 | 44 | | 2024 | 32 | 7 | 39 | | 2025 | 52 | 3 | 55 | | 2026 | 25 | 1 | 26 |
To return to the timeline, click here.
Below are the most recent publications written about "Brain Neoplasms" by people in Profiles.
-
Leuthardt EC, Chiang V, Hadjipanayis CG, Landazuri P, Placantonakis DG, Abram SR, Sun DA, Smith KA, Mohammadi AM, Chen CC, Williams BJ, Piccioni DE, Hodges TR, Sloan AE, Lega B, Rodriguez A, Lacroix M, Panov F, Razavi HB, Baumgartner J, Abel TJ, Bandt K, Smyth MD, Rao G, Fecci PE, Laxton AW, Tatter SB, Kim AH, Prabhu SS. Laser Interstitial Thermal Therapy for Brain Tumors: A Prospective Multicenter Analysis of Patients From the LAANTERN Study. J Clin Oncol. 2026 Sep 20; 44(27):2634-2644.
-
Chang-Gu B, Baljinnyam T, Sowers ML, Dilawari R, Herring J, Sowers L. Targeting the NAD+ Salvage Pathway Blocks Metabolic Recovery and Enhances ß-Lapachone Toxicity in NQO1-Expressing Glioblastoma Cells. Cancer Res Commun. 2026 Aug 01; 6(8):1836-1849.
-
Contreras-Zárate MJ, Jaramillo-Gómez JA, Marquez-Ortiz RA, Pham TC, Koliavas SN, Ormond DR, Navarro AC, Nemenoff RA, Camidge DR, Cittelly DM. Targeting Wild-type NTRK in NTRK Fusion-Negative Lung Cancer Decreases Brain Metastases. Cancer Res Commun. 2026 Aug 01; 6(8):1850-1861.
-
Srinivasan S, Eraghi MM, Odiase P, Mazumder S, Ahuja A, Ranganathan S, Patel P, O'Leary S, Guirguis M, Barrie U, Sun MZ, Patel A. Prognostic utility of tumor grade and IDH-mutation status for immunotherapy response in high grade glioma: a systematic review and meta-analysis. J Clin Neurosci. 2026 Oct; 152:112202.
-
Gray MT, Cayrol R, May A, Skaugen JM, Hayek F, Lapointe S, Hawkins CE, Pearce TM, Pratt D, Wiredja D, Toland A, Marker DF. Gliomas with succinate dehydrogenase deficiency: A case series and brief review of the literature of oncometabolite-driven gliomagenesis. J Neuropathol Exp Neurol. 2026 Jul 01; 85(7):789-796.
-
Lozzi B, Gatesman TA, Dasgupta P, Sardar D, Ko Y, Mao C, Chen HC, Curry RN, Choi D, Mohila CA, Bondy ML, Rao G, Gallo M, Agnihotri S, Deneen B. Hp1bp3 loss links chromatin reorganization to metabolic vulnerability in glioma. Proc Natl Acad Sci U S A. 2026 Jun 16; 123(24):e2601061123.
-
Sidpra J, Lind V, Cohen AL, Schaper FLWVJ, Stone TJ, Grabovska Y, Biswas A, Sudhakar S, Sepulveda F, Peres BS, Veronese G, Alemán-Charlet C, Ogunbiyi O, Shamardani K, Zhao J, Palacin AC, Miller G, Opipari RS, De Vita E, Ridout D, Ferraciolli SF, Lucato LT, Avsenik J, Piccirilli E, Morales-La Madrid A, Muchart J, Ryan ME, Patel R, Haldipur P, Hill CS, Krüger MT, Zrinzo L, Jeelani NUO, Martinez-Barbera JP, Donson AM, Dorris K, Morgan PS, Mackay A, Venkatesh HS, Horn A, Mueller S, Green AL, Mirsky DM, Akram H, Jones C, Aquilina K, Mankad K, Monje M, Jacques TS, Fox MD, Hargrave DR. A prognostic human brain network for diffuse midline glioma. Nature. 2026 Jul; 655(8123):769-779.
-
Crowell C, Mankuzhy NP, Bennett J, Bandopadhayay P, Sturm D, Green AL, Gupta T, Chatterjee A, Epari S, Chinnaswamy G, Prasad M, Patel SH, MacNeil M, Vanan MI, Larouche V, Renzi S, Jones J, Perreault S, Mata-Mbemba D, Sangatsuda Y, Yoshimoto K, Lin E, Feddersen C, Cruz O, Pavon-Mengual M, Vizzini O, Zápotocký M, Popovacki A, Klawinski D, Hansford JR, Schlosser MP, Omene E, Alexander KL, Satgunaseelan L, Williams A, Yao K, Ronsley R, Cheng S, Ludlow L, Eisenstat D, Khuong-Quang DA, Tabouret E, André N, Matheson K, Chan A, Lim-Fat MJ, Lapointe S, Cayrol R, Coleman C, Juretic N, McThenia S, Khan S, Wright-Nadkarni M, Salloum R, Galvin RT, Sener U, Hawkins C, Imber BS, Karajannis MA, Jones DTW, Ligon KL, Jabado N, Erker C. Clinical Outcomes and Prognostic Features of Diffuse Hemispheric Glioma, H3 G34-Mutant: An International Multi-institutional Study. Clin Cancer Res. 2026 Jun 01; 32(11):2243-2254.
-
Keane L, ?kandík M, Posada-Pérez M, Bose R, Desito J, van der Linde E, Engskog-Vlachos P, Ceccatelli S, Green AL, Joseph B. Microglia in diffuse midline glioma contribute to extracellular matrix remodelling and cancer cell invasion. Cell Death Dis. 2026 May 30; 17(1).
-
Fox MS, Jaramillo-Gómez JA, Marquez-Ortiz RA, Alvarez-Eraso KLF, Contreras-Zárate MJ, Pham TC, Barela EN, Koliavas SN, Kabos P, Serkova NJ, Sartorius CA, Wellberg EA, Cittelly DM. Brain FGF2 and NCAM1 contribute to FGFR1-dependent progression of estrogen receptor-positive breast cancer brain metastases. Nat Commun. 2026 May 28; 17(1).
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|